Drano: I agree completely with you that there is a parallel stock/approval/obfuscation/short and distort/hitpiece and headwinds trajectory between CYDY an NVAX. I have a small position in the later and watch the horrors unfold but not with the same heartburn as the former where the science of Leronlimab compelled me to an ever larger position.

I take the long view with both, true value always wins if you can wait for it so I hold, with firm conviction on the prospects of both. I watched a lengthy discussion by “Dr. Been” on YouTube a long while back pertaining to their vaccine and in his introduction he said “you are going to love this vaccine.” He is a phenomenal physician educator and has done educational sessions on Leronlimab also. His latest on novavax two weeks ago was related to the FDA review and there are some 15 links to novavax specific topics/updates he has covered…clearly the long road travelled.

Theirs is a superior vaccine and will win out like Leronlimab but I am truly appalled the headwinds and slow walking they have been subjected to…the same bad dream, different drug/vaccine. Wake me up when this is over and common sense prevails!